Navigation Links
Contraceptives Market is Expected to Reach USD 23.3 Billion Globally in 2018: Transparency Market Research
Date:5/14/2013

ALBANY, New York, May 14, 2013 /PRNewswire/ --

According to a new market report published by Transparency Market Research (http://www.transparencymarketresearch.com) "Contraceptives Market (Drugs, Devices, Pills, Hormonal & Copper IUDs, Vaginal Rings, Subdermal Implants, Topical Contraceptives, Injectables, Diaphragms, Sponges, Male & Female Condoms) - Global Industry Analysis, Size, Share, Growth and Forecast, 2012 - 2018," the global contraceptives market was valued at USD 16.0 billion in 2011 and is expected to grow at a CAGR of 5.5% from 2012 to 2018, to reach an estimated value of USD 23.3 billion in 2018.

Browse the full report at http://www.transparencymarketresearch.com/contraceptives-market.html

The growing prevalence of unwanted pregnancies across the globe especially in developed countries such as the U.S. will serve the market as a high impact rendering driver. This is principally due to the fact that governments of countries experiencing a rise in the prevalence of unwanted pregnancies are rigorously promoting the use of contraceptives to curb unnecessary healthcare expenditures associated with abortions. Some of the other drivers of the market include implementation of the Affordable Care Act in the U.S. which has accelerated the growth of the contraceptives market by widening the reimbursement options, rising number of initiatives undertaken by WHO, governments and other NGOs to elevate contraceptive related user awareness and rising global prevalence of sexually transmitted infections. The presence of a strong contraceptives product pipeline and the presence of large unmet contraceptive needs in emerging Asian and African economies will serve the global contraceptives market with future growth opportunities.

In the global contraceptives market by product types (drugs and devices), the contraceptive devices market held majority of the market share in 2011. Moreover, it is expected to exhibit the fastest growth rate during the forecast period owing to its high usage rates and the introduction of new and technologically advanced products such as Bayer's Skyla/Jaydess (a hormonal IUD) in 2012 in Europe and in 2013 in the U.S. The male contraceptive devices (male condoms) market held majority of the market share in 2011 at over 45% owing to its high usage rates induced by its easy-to-use features, cheap prices and high effectiveness. The subdermal contraceptive implants is one of the fastest growing segments in the global contraceptive devices market due to the rising popularity of cheap implants such as Sino-implant (II) and the price reduction of Bayer's Jadelle.

Related & Recently Published Reports by Transparency Market Research

http://www.transparencymarketresearch.com/computational-biology.html

http://www.transparencymarketresearch.com/peripheral-vascular-devices-market.html

http://www.transparencymarketresearch.com/nephrology-and-urology-devices-market.html

http://www.transparencymarketresearch.com/medical-robotic-systems.html

http://www.transparencymarketresearch.com/breast-pumps-market.html

Oral contraceptive pills are the most popular form of temporary birth control and it held majority of the market share in 2011. The global topical contraceptives market is the second fastest growing market after contraceptive pills. Its growth rate is justified by the possible introduction of new products such as AG200-15 by Agile Therapeutics in 2014.

The North American contraceptives market held majority of the market share in 2011 on account of high contraceptive drug usage rate in the region. In addition, the Asian contraceptives market is the fastest growing one due to presence of high unmet contraceptive needs in this region coupled with the rapidly developing economies of India and China.

Some of the key players in the market include Bayer, Church & Dwight Company, Warner Chilcott Company, Agile Therapeutics, BioSante Pharmaceuticals, Mayer Laboratories and others.

Related & Recently Published Reports by Transparency Market Research

http://www.transparencymarketresearch.com/fundus-cameras.html

http://www.transparencymarketresearch.com/biopsy-devices-market.html

http://www.transparencymarketresearch.com/medical-gases-and-equipment.html

http://www.transparencymarketresearch.com/radiofrequency-ablation-devices.html

http://www.transparencymarketresearch.com/implantable-drug-delivery-devices.html

The global contraceptive market is categorized into the following segments:

  • Contraceptives Market by Products
    • Contraceptive Drugs
      • Oral Contraceptive Pills
      • Contraceptive Injectables
      • Topical Contraceptives
    • Contraceptive Devices
      • Male Contraceptive Devices (Male Condoms)
      • Female Contraceptive Devices
        • Female Condoms
        • Diaphragms
        • Sponges
        • IUDs
          • Hormonal IUDs
          • Copper IUDs
        • Subdermal Contraceptive Implants
        • Vaginal Rings

  • Contraceptives Market by Geography
    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World (RoW)

Upcoming Reports in Medical Devices Market

Radiation Detection Market

Pre-Clinical Imaging Market

Diagnostic Electrocardiograph Market

Medical Plastics Market

Computational Biology

Nanomedical Market

Medical Bionic Implant Market

Orthopedics Market

Endoscopy Device Market

E-Prescribing Market

Browse all Medical Devices Market Research Reports@ http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Visit: http://de.transparencymarketresearch.com/
Visit: http://www.europlat.org/
Visit: http://www.transparencymarketresearch.com/


'/>"/>
SOURCE Transparency Market Research
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. MarketsandMarkets: Lung Cancer Drugs Market in G7 Countries Worth $13 Billion by 2020
2. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
3. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
4. Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
5. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
6. MarketsandMarkets: Leukemia Therapeutics Market Worth $11.3 Billion by 2020
7. ResearchMoz: Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market
8. GeneLink Marketing Efforts Poised to Show Results
9. Animal Biotechnology - Technologies, Markets and Companies
10. Gene Therapy - Technologies, Markets and Companies
11. Biomarkers - Technologies, Markets and Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... TARRYTOWN, N.Y. , March 22, 2017 Regeneron ... among the Regeneron Genetics Center (RGC), U.K. Biobank and GSK ... in the U.K. Biobank resource. The initiative will enable researchers ... of new medicines for a wide range of serious and ... ...
(Date:3/22/2017)... March 22, 2017  Ascendis Pharma A/S (Nasdaq: ... TransCon technology to address significant unmet medical needs ... the full year ended December 31, 2016. ... our company as we broadened our pipeline and ... rare disease company with an initial focus on ...
(Date:3/22/2017)... Mass. , March 22, 2017 Good ... that it has eclipsed the 130 million covered lives ... Blue Shield of Texas . With ... the Company continues to enjoy strong payor acceptance based ... its clinical programs and genetic counseling, its industry-leading customer ...
(Date:3/22/2017)... --  iSpecimen ®, the marketplace for human ... (DPS), a full-service anatomic pathology reference lab serving ... , has joined a program offered by iSpecimen ... to make human biospecimens and associated data available to ... in 2015 as a collaboration between iSpecimen and DHIN, ...
Breaking Biology Technology:
(Date:3/24/2017)... , Mar 24, 2017 Research and ... Access System Market Analysis & Trends - Industry Forecast to 2025" ... ... to grow at a CAGR of around 15.1% over the next ... This industry report analyzes the market estimates and forecasts for all ...
(Date:3/22/2017)... YORK , March 21, 2017 ... Marketing Cloud used by retailers such as 1-800-Flowers ... its platform — Product Recommendations and Replenishment. Using Optimove,s ... give more personalized product and replenishment recommendations to ... but also on predictions of customer intent drawn ...
(Date:3/16/2017)... CeBIT 2017 - Against identity fraud with DERMALOG solutions "Made in Germany ... ... one project, multi-biometric solutions provide a crucial contribution against identity fraud. (PRNewsFoto/Dermalog Identification Systems) ... Used combined in one project, multi-biometric solutions provide a crucial contribution ... ...
Breaking Biology News(10 mins):